---
title: Coherus Biosciences' Outsourcing Strategy
description: (09/28/2014) With Coherus Biosciences’ $86 Million IPO announced last week, we wanted to take a closer look at the companies that stand to benefit the most from the upcoming injection of capital.
image: https://blog.zymewire.com/hubfs/Imported_Blog_Media/5afb46905a42002545e550cf_accounting-blur-budget-128867-1.jpg
---

[![arrow](https://blog.zymewire.com/hubfs/zymewire-2022/images/back%20arrow.svg)](https://blog.zymewire.com)

# Coherus Biosciences' Outsourcing Strategy

##### October 15, 2019 | Pete Bastedo | Industry Articles

*Originally published by Zymewire on 09/28/2014.*

‍

With Coherus Biosciences’  $86 Million IPO announced last week, we wanted to take a closer look at the companies that stand to benefit the most from the upcoming injection of capital.  On the contract research side, Medpace appears to be in a strategic position to block further CRO’s from getting the biosimilar study business (see graphic).  The contract manufacturing equation is more diverse with Cook, KBI, Rentschler, and Catalent all getting a piece of the action.  Two fill finish opportunities still exist as of the time of this blog post.  Check out the graphic for the the full breakdown.   

![Diagram of Coherus BiosSciences outsourcing CRO CMO vendor strategy](https://blog.zymewire.com/hubfs/Imported_Blog_Media/cme5UPE-1.jpg)

### Comments

#### Share it on

- ![Twitter](https://blog.zymewire.com/hubfs/zymewire-2022/images/brandico_twitter-bird.svg)
- ![Linkedin](https://blog.zymewire.com/hubfs/zymewire-2022/images/eva_linkedin-fill.svg)
- ![Facebook](https://blog.zymewire.com/hubfs/zymewire-2022/images/brandico_facebook.svg)

### Subscribe now

## Related blogs

##### [![When M&A Should Drive Sales, Why Does It Often Do the Opposite?](https://blog.zymewire.com/hs-fs/hubfs/Zymewire_%20M%26A%20Blog%20Cover.png?A%20Blog%20Cover.png&width=500&name=Zymewire_%20M%26A%20Blog%20Cover.png?A%20Blog%20Cover.png) When M&A Should Drive Sales, Why Does It Often Do the Opposite? In the fast-paced world of life sciences, mergers and acquisitions (M&A) are often seen as a golden ticket to growth. But what happens ... 21 Apr, 2025](https://blog.zymewire.com/when-ma-should-drive-sales-why-does-it-often-do-the-opposite)

##### [![Biopharma Recap: Q3 2024](https://blog.zymewire.com/hs-fs/hubfs/Q3%202024%20Biopharma%20Recap%20(Zymewire).png?width=500&name=Q3%202024%20Biopharma%20Recap%20(Zymewire).png) Biopharma Recap: Q3 2024 In our Q3 2024 biopharma recap, we dive into the latest trends in funding, clinical trial activity, and therapeutic focus areas across the ... 15 Oct, 2024](https://blog.zymewire.com/biopharma-recap-q3-2024)

##### [![Q2 Biopharma Recap](https://blog.zymewire.com/hs-fs/hubfs/Q2%20Biopharma%20Recap%20Cover.png?width=500&name=Q2%20Biopharma%20Recap%20Cover.png) Q2 Biopharma Recap As the second quarter of 2024 comes to a close, the biopharma landscape continues to evolve with dynamic shifts in funding, clinical ... 24 Jul, 2024](https://blog.zymewire.com/q2-biopharma-recap)

## Custom built for biotech and pharma

We are obsessed with finding new ways to help your business generate more qualified leads.

Our human-verified AI scans thousands of documents every day, separates the signal from the noise, and delivers value in the form of actionable sales intelligence.

Demo Zymewire

### Book a Demo

- Access stealth biotech companies
- Never miss a sales signal
- Find whitespace in your sales territory

```json
{
  "@context" : "https://schema.org",
  "@type" : "BlogPosting",
  "author" : {
    "@type" : "Person",
    "name" : "Pete Bastedo",
    "url" : "https://blog.zymewire.com/author/pete-bastedo"
  },
  "dateModified" : "2021-07-01T01:28:12.685Z",
  "datePublished" : "2019-10-15T04:00:00.000Z",
  "headline" : "Coherus Biosciences' Outsourcing Strategy",
  "image" : [ "https://blog.zymewire.com/hubfs/Imported_Blog_Media/5afb46905a42002545e550cf_accounting-blur-budget-128867-1.jpg" ],
  "mainEntityOfPage" : {
    "@id" : "https://blog.zymewire.com/post/coherus-biosciences-outsourcing-strategyname",
    "@type" : "WebPage"
  },
  "publisher" : {
    "@type" : "Organization",
    "logo" : {
      "@type" : "ImageObject",
      "url" : "https://blog.zymewire.com/hubfs/white_logo.jpg"
    }
  }
}
```